SG11201700595RA - Aldosterone synthase inhibitors - Google Patents
Aldosterone synthase inhibitorsInfo
- Publication number
- SG11201700595RA SG11201700595RA SG11201700595RA SG11201700595RA SG11201700595RA SG 11201700595R A SG11201700595R A SG 11201700595RA SG 11201700595R A SG11201700595R A SG 11201700595RA SG 11201700595R A SG11201700595R A SG 11201700595RA SG 11201700595R A SG11201700595R A SG 11201700595RA
- Authority
- SG
- Singapore
- Prior art keywords
- synthase inhibitors
- aldosterone synthase
- aldosterone
- inhibitors
- synthase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462028556P | 2014-07-24 | 2014-07-24 | |
| PCT/US2015/041648 WO2016014736A1 (en) | 2014-07-24 | 2015-07-23 | Aldosterone synthase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201700595RA true SG11201700595RA (en) | 2017-02-27 |
Family
ID=53761616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201700595RA SG11201700595RA (en) | 2014-07-24 | 2015-07-23 | Aldosterone synthase inhibitors |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US9334285B2 (ja) |
| EP (1) | EP3172212B1 (ja) |
| JP (1) | JP6250862B2 (ja) |
| KR (1) | KR102378648B1 (ja) |
| CN (1) | CN106488921B (ja) |
| AP (1) | AP2016009616A0 (ja) |
| AR (1) | AR101290A1 (ja) |
| AU (1) | AU2015292632B2 (ja) |
| BR (1) | BR112017000584B1 (ja) |
| CA (1) | CA2956118C (ja) |
| CL (1) | CL2017000040A1 (ja) |
| CO (1) | CO2017000443A2 (ja) |
| CY (1) | CY1121063T1 (ja) |
| DK (1) | DK3172212T3 (ja) |
| EA (1) | EA031105B1 (ja) |
| ES (1) | ES2684050T3 (ja) |
| HR (1) | HRP20181441T1 (ja) |
| HU (1) | HUE039981T2 (ja) |
| IL (1) | IL249665B (ja) |
| LT (1) | LT3172212T (ja) |
| MX (1) | MX368093B (ja) |
| MY (1) | MY191352A (ja) |
| NZ (1) | NZ727188A (ja) |
| PE (1) | PE20170294A1 (ja) |
| PH (1) | PH12017500089A1 (ja) |
| PL (1) | PL3172212T3 (ja) |
| PT (1) | PT3172212T (ja) |
| RS (1) | RS57570B1 (ja) |
| SG (1) | SG11201700595RA (ja) |
| SI (1) | SI3172212T1 (ja) |
| TW (1) | TWI600658B (ja) |
| UA (1) | UA118801C2 (ja) |
| UY (1) | UY36228A (ja) |
| WO (1) | WO2016014736A1 (ja) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2724555T3 (es) * | 2014-10-15 | 2019-09-12 | Boehringer Ingelheim Int | Inhibidores de la aldosterona sintasa |
| EP3227300B1 (en) * | 2014-12-02 | 2019-06-19 | Boehringer Ingelheim International GmbH | Aldosterone synthase inhibitors |
| JP6914974B2 (ja) | 2016-06-28 | 2021-08-04 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 腎疾患、心血管疾患、および線維性障害の治療に有用な二環式イミダゾール誘導体 |
| SG10201610038SA (en) * | 2016-07-29 | 2017-12-28 | Apple Inc | Systems and methods for management of asymmetrical multi-tapped battery packs |
| EP3962903A1 (en) | 2019-05-01 | 2022-03-09 | Boehringer Ingelheim International GmbH | (r)-(2-methyloxiran-2-yl)methyl 4-bromobenzenesulfonate |
| WO2023114170A1 (en) | 2021-12-14 | 2023-06-22 | Boehringer Ingelheim International Gmbh | Aldosterone synthase inhibitors for treating chronic kidney disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100703068B1 (ko) * | 2003-12-30 | 2007-04-05 | 에스케이케미칼주식회사 | 피리딘 유도체와 이의 제조방법, 및 이를 포함하는약제조성물 |
| BRPI0709678A2 (pt) * | 2006-03-29 | 2011-07-19 | Novartis Ag | compostos orgánicos |
| TW200808813A (en) * | 2006-04-12 | 2008-02-16 | Speedel Experimenta Ag | Imidazo compounds |
| TWI577671B (zh) * | 2011-11-14 | 2017-04-11 | Sunshine Lake Pharma Co Ltd | Aminoquinazoline derivatives and salts thereof and methods of use thereof |
| US8912341B2 (en) * | 2013-01-16 | 2014-12-16 | Northwestern University | Enantioselective N-heterocyclic carbene-catalyzed annulation reactions with imidazolidinones |
-
2015
- 2015-07-23 KR KR1020177005181A patent/KR102378648B1/ko active IP Right Grant
- 2015-07-23 PT PT15744459T patent/PT3172212T/pt unknown
- 2015-07-23 WO PCT/US2015/041648 patent/WO2016014736A1/en active Application Filing
- 2015-07-23 HU HUE15744459A patent/HUE039981T2/hu unknown
- 2015-07-23 AU AU2015292632A patent/AU2015292632B2/en active Active
- 2015-07-23 MY MYPI2016002216A patent/MY191352A/en unknown
- 2015-07-23 UA UAA201701595A patent/UA118801C2/uk unknown
- 2015-07-23 RS RS20180970A patent/RS57570B1/sr unknown
- 2015-07-23 BR BR112017000584-0A patent/BR112017000584B1/pt active IP Right Grant
- 2015-07-23 AR ARP150102340A patent/AR101290A1/es unknown
- 2015-07-23 CA CA2956118A patent/CA2956118C/en active Active
- 2015-07-23 PL PL15744459T patent/PL3172212T3/pl unknown
- 2015-07-23 NZ NZ727188A patent/NZ727188A/en unknown
- 2015-07-23 PE PE2017000086A patent/PE20170294A1/es unknown
- 2015-07-23 ES ES15744459.7T patent/ES2684050T3/es active Active
- 2015-07-23 JP JP2017503920A patent/JP6250862B2/ja active Active
- 2015-07-23 SG SG11201700595RA patent/SG11201700595RA/en unknown
- 2015-07-23 TW TW104123931A patent/TWI600658B/zh active
- 2015-07-23 US US14/806,706 patent/US9334285B2/en active Active
- 2015-07-23 DK DK15744459.7T patent/DK3172212T3/en active
- 2015-07-23 EP EP15744459.7A patent/EP3172212B1/en active Active
- 2015-07-23 LT LTEP15744459.7T patent/LT3172212T/lt unknown
- 2015-07-23 CN CN201580036596.3A patent/CN106488921B/zh active Active
- 2015-07-23 SI SI201530354T patent/SI3172212T1/sl unknown
- 2015-07-23 EA EA201790253A patent/EA031105B1/ru not_active IP Right Cessation
- 2015-07-23 AP AP2016009616A patent/AP2016009616A0/en unknown
- 2015-07-23 MX MX2017000929A patent/MX368093B/es active IP Right Grant
- 2015-07-24 UY UY0001036228A patent/UY36228A/es active IP Right Grant
-
2016
- 2016-12-20 IL IL249665A patent/IL249665B/en active IP Right Grant
-
2017
- 2017-01-06 CL CL2017000040A patent/CL2017000040A1/es unknown
- 2017-01-13 PH PH12017500089A patent/PH12017500089A1/en unknown
- 2017-01-19 CO CONC2017/0000443A patent/CO2017000443A2/es unknown
-
2018
- 2018-09-04 CY CY181100920T patent/CY1121063T1/el unknown
- 2018-09-07 HR HRP20181441TT patent/HRP20181441T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287113A (en) | smyd inhibitors | |
| ZA201701846B (en) | Spirodiamine derivatives as aldosterone synthase inhibitors | |
| HK1244792B (zh) | 壞死抑制劑 | |
| IL246785A0 (en) | Benzimidazole-2-amines as midh1 inhibitors | |
| GB201421083D0 (en) | Enzyme inhibitors | |
| HK1226398A1 (zh) | 作為midh1抑制劑的苯並咪唑-2-胺 | |
| GB201421088D0 (en) | New enzyme inhibitors | |
| IL248895A0 (en) | Phosphatidylinositol 3-kinase inhibitors | |
| HK1244480A1 (zh) | 細胞壞死抑制劑 | |
| GB201421085D0 (en) | New enzyme inhibitors | |
| HRP20181441T1 (hr) | Inhibitori sintaze aldosterona | |
| IL251200B (en) | Aldosterone synthase inhibitors | |
| GB201400299D0 (en) | Corrosion inhibitors | |
| ZA201903149B (en) | Aldosterone synthase inhibitor | |
| HK1232215A1 (zh) | 作為醛固酮合酶抑制劑的新型二氫喹啉吡唑基化合物 | |
| IL249234A0 (en) | Osteoclast inhibitors for pain management | |
| GB201418154D0 (en) | Inhibitors | |
| GB201400300D0 (en) | Corrosion inhibitors | |
| AU2014900535A0 (en) | Inhibitors |